The Readout Loud

Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file